These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30133929)

  • 1. Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream.
    Plachouri KM; Balasis S; Mallioris AF; Koumoundourou D; Georgiou S
    Dermatol Ther; 2018 Sep; 31(5):e12685. PubMed ID: 30133929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream.
    Yang JQ; Chen XY; Engle MY; Wang JY
    Dermatol Ther; 2015; 28(4):243-7. PubMed ID: 25754701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature.
    Drehs MM; Cook-Bolden F; Tanzi EL; Weinberg JM
    Dermatol Surg; 2002 May; 28(5):427-9. PubMed ID: 12030878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream.
    Hannuksela-Svahn A; Nordal E; Christensen OB
    Acta Derm Venereol; 2000; 80(5):381-2. PubMed ID: 11200841
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
    Bostanci S; Kocyigit P; Vural S; Heper AO; Botsali A
    Dermatol Surg; 2018 Jan; 44(1):36-41. PubMed ID: 29016542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod.
    Latour I; Hernández-Martín A; Ged C; Knöpfel N; Taïeb A; Torrelo A
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e282-e284. PubMed ID: 29377344
    [No Abstract]   [Full Text] [Related]  

  • 8. Imiquimod 5% Cream as Adjuvant Therapy in BCC Treatment Located at High-Risk Regions.
    Cengiz FP; Kelahmetoglu O; Emiroglu N; Onsun N
    J Cutan Med Surg; 2020; 24(6):640-641. PubMed ID: 32558591
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
    Kocabaş E; Ermertcan AT; Bilaç C; Bilaç DB; Temiz P
    Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.
    Huber A; Huber JD; Skinner RB; Kuwahara RT; Haque R; Amonette RA
    Dermatol Surg; 2004 Mar; 30(3):429-30. PubMed ID: 15008876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series.
    Kaçar SD; Özuğuz P; Erkan F; Karaca Ş
    J Dermatolog Treat; 2015 Apr; 26(2):165-7. PubMed ID: 24731081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
    Vidal D; Matías-Guiu X; Alomar A
    Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into imiquimod skin permeation and increased delivery using microneedle pre-treatment.
    Al-Mayahy MH; Sabri AH; Rutland CS; Holmes A; McKenna J; Marlow M; Scurr DJ
    Eur J Pharm Biopharm; 2019 Jun; 139():33-43. PubMed ID: 30771455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome.
    Drummond A; Pichler J; Argenziano G; Zalaudek I; Longo C; Lallas A; Piana S; Moscarella E
    Australas J Dermatol; 2015 Nov; 56(4):e105-7. PubMed ID: 24575881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
    Jansen MHE; Mosterd K; Arits AHMM; Roozeboom MH; Sommer A; Essers BAB; van Pelt HPA; Quaedvlieg PJF; Steijlen PM; Nelemans PJ; Kelleners-Smeets NWJ
    J Invest Dermatol; 2018 Mar; 138(3):527-533. PubMed ID: 29045820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
    Peris K; Campione E; Micantonio T; Marulli GC; Fargnoli MC; Chimenti S
    Dermatol Surg; 2005 Mar; 31(3):318-23. PubMed ID: 15841634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series.
    Ruiz-Villaverde R; Sánchez-Cano D; Burkhardt-Pérez P
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):828-31. PubMed ID: 19646136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
    Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
    Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp.
    Tauber G; Pavlovsky L; Fenig E; Hodak E
    J Am Acad Dermatol; 2015 Nov; 73(5):799-801. PubMed ID: 26320385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.